publication venue for
- Ultraviolet light exposure from manicures in cutaneous lupus erythematosus. 2022
- Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials. 2021
- Inflammatory arthritis complicating mogamulizumab treatment of Sézary syndrome. 2023
- Comparison of two frailty definitions in women with systemic lupus erythematosus. 2023
- Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry. 2023
- Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab.. 62. 2023
- Damage measured by damage index for antiphosphlipid syndrome in antiphospholipid antibody-positive patients included in APS ACTION Registry. 2023
- Prognostic and predictive markers of systemic sclerosis-interstitial lung disease in a clinical trial and long-term observational cohort. 2023
- Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial.. 62. 2023
- Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.. 62. 2023
- CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization. 2023
- Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment-specific patient-reported outcome measure. 2023
- Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program. 2022
- Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: Clinical and histopathological associations. 2022
- New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.. 61. 2022
- Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis.. 61. 2022
- Axonal dysfunction is associated with interferon-γ levels in childhood-onset systemic lupus erythematosus: a multivoxel magnetic resonance spectroscopy study.. 61. 2022
- Clinical integration of patient-reported outcome measures to enhance the care of patients with SLE: a multi-center prospective cohort study. 2022
- Prevalence of frailty in patients with polymyalgia rheumatica and association with health-related quality of life, cognition and sarcopenia. 2022
- Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study.. 61. 2022
- Hospital readmission in systemic sclerosis associated pulmonary hypertension: Results from the PHAROS registry. 2021
- The Attitudes and Practices of Physicians Caring for Patients with Rheumatoid Arthritis-Interstitial Lung Disease: An International Survey. 2021
- US rheumatologists' beliefs and knowledge about biosimilars: a survey.. 60. 2021
- Patients and Clinicians Define Symptom Levels and Meaningful Change for PROMIS Pain Interference and Fatigue in RA using Bookmarking. 2021
- Unique Sjögren's syndrome patient subsets defined by molecular features.. 59. 2020
- Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.. 59. 2020
- The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts.. 57. 2018
- Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.. 57. 2018
- The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients.. 57. 2018
- Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.. 57. 2018
- The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies.. 57. 2018
- Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis.. 56. 2017
- The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.. 56. 2017
- Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis.. 56. 2017
- Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension.. 56. 2016
- Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment.. 55. 2016
- Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort.. 55. 2016
- A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis.. 55. 2016
- Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis.. 54. 2014
- Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.. 53. 2013
- A parallel group cohort to determine the measurement properties of an early inflammatory arthritis detection tool.. 52. 2013
- Low prevalence of coeliac disease in patients with systemic sclerosis: a cross-sectional study of a registry cohort.. 52. 2013
- Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.. 51. 2012
- Fibrocyte activation in rheumatoid arthritis.. 49. 2009
- Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers.. 47 Suppl 3. 2008
- Chronic inflammation modulates ghrelin levels in humans and rats.. 43. 2003
- Acupuncture for chronic low back pain in older patients: a randomized, controlled trial.. 42. 2003
- A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome.. 41. 2002
- Renal arteriovenous fistula in Behçet's disease.. 60. 2021
- More than meets the eye: IgG4-related disease presenting as isolated interstitial lung disease.. 56. 2017
- Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis. 2021
- Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. 2008
- Has TNF inhibitor use decreased the need for total hip and total knee replacement for patients with RA?. 58. 2019
- Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.. 58. 2019
- Management of rheumatoid arthritis.. 53. 2014
- The times they are a changin'.. 52. 2013
- The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis. 2019
- Cardiac arrhythmias and conduction defects in systemic sclerosis. 2013
- Pregnancy and reproduction in autoimmune rheumatic diseases. 2010
- Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. 2007
- Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials. 2020
- Towards a pro-inflammatory and immunomodulatory emerging role of leptin. 2006